Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).
Saved in:
| Title: | Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS). |
|---|---|
| Authors: | Stepien KM; Northern Care Alliance NHS Foundation Trust, Salford, UK. karolina.stepien@nca.nhs.uk., Burton BK; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Bober MB; Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, USA., Campeau PM; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada., Ellaway C; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia., Bhattacharya K; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia., Guffon N; Reference Centre of Inherited Metabolic Disease, Hospices Civils de Lyon, Lyon, France., Hinds D; BioMarin Pharmaceutical Inc., Novato, CA, USA., Hunt A; BioMarin Pharmaceutical Inc., Novato, CA, USA., Lail A; BioMarin Pharmaceutical Inc., Novato, CA, USA., Lin SP; MacKay Children's Hospital, Taipei, Taiwan., Magner M; Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic., Murphy E; National Hospital for Neurology and Neurosurgery, London, UK., Reisewitz P; BioMarin Pharmaceutical Inc., Novato, CA, USA., Mitchell JJ; McGill University Health Centre, Montreal, Quebec, Canada. |
| Source: | Orphanet journal of rare diseases [Orphanet J Rare Dis] 2025 Oct 30; Vol. 20 (1), pp. 548. Date of Electronic Publication: 2025 Oct 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41168830 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stepien+KM%22">Stepien KM</searchLink>; Northern Care Alliance NHS Foundation Trust, Salford, UK. karolina.stepien@nca.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Burton+BK%22">Burton BK</searchLink>; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Bober+MB%22">Bober MB</searchLink>; Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Campeau+PM%22">Campeau PM</searchLink>; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Ellaway+C%22">Ellaway C</searchLink>; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+K%22">Bhattacharya K</searchLink>; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Guffon+N%22">Guffon N</searchLink>; Reference Centre of Inherited Metabolic Disease, Hospices Civils de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Hinds+D%22">Hinds D</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hunt+A%22">Hunt A</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lail+A%22">Lail A</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+SP%22">Lin SP</searchLink>; MacKay Children's Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Magner+M%22">Magner M</searchLink>; Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Murphy+E%22">Murphy E</searchLink>; National Hospital for Neurology and Neurosurgery, London, UK.<br /><searchLink fieldCode="AU" term="%22Reisewitz+P%22">Reisewitz P</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+JJ%22">Mitchell JJ</searchLink>; McGill University Health Centre, Montreal, Quebec, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101266602%22">Orphanet journal of rare diseases</searchLink> [Orphanet J Rare Dis] 2025 Oct 30; Vol. 20 (1), pp. 548. <i>Date of Electronic Publication: </i>2025 Oct 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101266602 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-1172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217501172%22">17501172 </searchLink><i>NLM ISO Abbreviation: </i>Orphanet J Rare Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41168830 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13023-025-04064-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 548 Titles: – TitleFull: Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stepien KM – PersonEntity: Name: NameFull: Burton BK – PersonEntity: Name: NameFull: Bober MB – PersonEntity: Name: NameFull: Campeau PM – PersonEntity: Name: NameFull: Ellaway C – PersonEntity: Name: NameFull: Bhattacharya K – PersonEntity: Name: NameFull: Guffon N – PersonEntity: Name: NameFull: Hinds D – PersonEntity: Name: NameFull: Hunt A – PersonEntity: Name: NameFull: Lail A – PersonEntity: Name: NameFull: Lin SP – PersonEntity: Name: NameFull: Magner M – PersonEntity: Name: NameFull: Murphy E – PersonEntity: Name: NameFull: Reisewitz P – PersonEntity: Name: NameFull: Mitchell JJ IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 10 Text: 2025 Oct 30 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1750-1172 Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: Orphanet journal of rare diseases Type: main |
| ResultId | 1 |